drugset / Trial / NCT04448496
Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the investigator's study is to evaluate the efficacy and safety profile of the pro re nata (PRN) regimen to 12 months by using intravitreal dexamethasone implant in eyes with treatment-naive diabetic macular edema patients.
Timeline
- Start
- 2020-06-22
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 0.7 mg | Intravitreal |